If this message is not displayed correctly, click here.


No 104, May 2017


Coming Soon on ENP: An Interactive Educational Programme on Hyperkalaemia

Hyperkalaemia is prevalent in chronic kidney disease, with a frequency of up to 40–50% in advanced stages of disease, and its occurrence increasing the odds of mortality within one day of a hyperkaelaemic event (Kovesdy CP. Nat Rev Nephrol 2014;10:653–662, Einhorn LM, et al. Arch Intern Med 2009;169:1156–1162).


To support the nephrology community with tackling the risk and impact of hyperkalaemia, a high-quality, peer-reviewed educational programme on the condition, sponsored by Astra-Zeneca (but with ERA-EDTA having the right to verify and approve (or not) the content), will be soon available on ENP.
Through a variety of interactive and visual contents, the programme will comprise modules which provide cutting-edge scientific evidence to support clinical decisions and address issues in the management in hyperkalaemia, such as:

•Which patients are at highest risk

•Strategies for reducing the burden of hyperkalaemia on patients

•When to start treatment for hyperkalaemia, and for how long

•Best practice for working with other specialities in the management of hyperkalaemia

•Reducing the burden of hyperkalaemia on healthcare systems


Subsequent modules available later in the year will explore the potential role for novel agents in improving the current standard of care.

Please look out for further updates on the launch of this exciting new educational programme.


What do you do back home after experiencing all the exciting sessions at ERA-EDTA-2017? Deepen your learning, educate peers and colleagues back home, implement the learning and adjust your practice?

This year ERA-EDTA provides 2017 Congress members with extended, new innovative services to help meet the educational requirements of participants, during and after the meeting. As in previous years, Congress members will be able to instantly access speaker presentation slides and webcasts, industry symposia, abstractsfor  this last matter (after having your badge scanned at the Vifor Fresenius Medical Care Renal Pharma Booth 3.020 in Hall 8), e-posters and articles. But how to easily create a summary out of the materials that you can share with colleagues? The new Summary Builder allows to: a) select slides of available presentations, either online or via the congress mobile app; b) to add notes under each slide during or after a presentation and, c) to configure your own summary (fully cited) PDF document. While you review the exciting ERA-EDTA 2017 content and you come across a question or want to add a thought you can reach the participating faculty of a selected number of sessions via the new Dialogue module. Benefit from the new digital educational services when you attend ERA-EDTA 2017 via your ENP account and a valid badge number. Go to www.enp-era-edta.org and click on E-materials 2017.

Want a demo? Visit the e-campus on site in Hall 10 of the IFEMA congress centre.

ndt and ckj articles

Just published online! Read the latest NDT and CKJ articles

Should more steps be taken to make kidney patients quit smoking?

Yes, at least this is the opinion of Steven Van Laecke and Wim Van Biesen, authors of the NDT article “Smoking and chronic kidney disease: seeing the signs through the smoke?”. It is indeed a generally known fact that smoking promotes the development of kidney fibrosis, thus leading to a faster decline of kidney function. Evidence suggests a role of smoking on the incidence and progression of CKD, irrespective of the original native disease. As the Belgian authors argue, the solid evidence of a substantial negative impact of smoking should lead the nephrological community to take action. Anti-tobacco campaigns and cessation programs might help – and there is still the debate on the prerequisite of non-smoking for transplant candidates which might be effective.

Compact update on acute kidney injury

Acute kidney injury (AKI) is a complex condition. This review, published in CKJ, gives an up-to-dated overview of clinical management. It focuses on the classification, diagnostic methods and clinical management that are available, or promising, for patients with AKI. Furthermore, preventive measures with fluids, acetylcysteine, statins and remote ischemic preconditioning, as well as when to start dialysis in AKI patients are discussed.


ERA-EDTA Ordinary Council Member Elections 2017

On June 5, 2017 during the ERA-EDTA General Assembly (held at the 54th ERA-EDTA Congress) in Madrid (Spain), three Ordinary Council Members must be elected as A. Argiles (Spain), P. Evenepoel (Belgium) and A. Ortiz (Spain) will have completed their terms.

All full ERA-EDTA members will be able to vote for a maximum of three candidates (click here to read the list of the 2017 Ordinary Council Member Candidates). Only electronic voting will be available before the Congress and onsite during the Madrid Congress and will be open until the start of the General Assembly at 9.30 (CEST) on June 5, 2017.

The General Assembly will be held in Room N117-118, Level 1, IFEMA North Congress Center, Madrid (Spain), and all ERA-EDTA members are welcome to attend.

Web Site

ERA-EDTA Flash is the official ERA-EDTA eNewsletter

Editor-in-Chief: Mustafa Arici
Editorial Secretariat: Valentina Cocchi
Newsletter Design: Ilaria Martini

ERA-EDTA Headquarters
Via XXIV Maggio, 38
43123 Parma - Italy


The ERA-EDTA collects and processes personal information to provide you with details regarding the Association and its activities. The information is used for accounting and commercial purposes by ERA-EDTA and/or Euromeetings s.r.l. in compliance with the Italian Legislative Decree 196/2003. If at any time you wish to change personal information that is incorrect or wish to have your personal data deleted, please REPLY this email and specify ‘REMOVE ME FROM YOUR DATABASE’. ERA-EDTA will meet such requests at the earliest possible opportunity by deleting or amending your personal information.